• Noksprey (Oxymetazoline) 0.5mg/ml 20ml nasal spray

Expiration date: 12/2025

The composition and form of issue:

Nasal spray. 1 ml contains Oxymetazoline hydrochloride 0.5 mg

auxiliary substances: camphor racemic menthol evkaliptola sodium phosphate disodium, sodium edetate (Trilon B), benzalkonium chloride propylene glycol purified water 

10 or 20 ml in plastic bottles with stoppers, nozzles and screw caps with tamper-evident in the paper cartons 1 a bottle.

Description pharmaceutical form:

Colorless or slightly yellowish, transparent liquid with a specific smell.

Description pharmacological action:

Oxymetazoline hydrochloride causes vasoconstriction of the mucous membranes of the nose, paranasal sinuses and the Eustachian tube, which causes a soft and long-lasting reduction in the swelling and leads to relief of nasal breathing. Relief of nasal breathing occurs within 5-10 min after injection into the cavity of the nose and lasts for about 10-12 hours.

Indications:

To facilitate nasal breathing in case of:

  • colds
  • flu
  • respiratory viral infections
  • acute rhinitis
  • sinusitis.

Contraindications:

  • hypersensitivity to the drug
  • atrophic rhinitis
  • pregnancy, lactation
  • children up to age 6 years.

Caution: diseases of the cardiovascular system (hypertension, ischemic heart disease, congestive heart failure, tachycardia, arrhythmia) angle-closure glaucoma, hyperthyroidism diabetes mellitus pheochromocytoma chronic renal failure, simultaneous reception of MAO inhibitors, tricyclic antidepressants.

Application of pregnancy and breast-feeding:

During pregnancy and breastfeeding the drug should be prescribed only if clearly needed, when the benefits to the mother exceed the risk to the fetus or child.

Side effects:

Temporary dryness and irritation of the mucous membrane of the nasal cavity, dry mouth and throat, sneezing, increase in the volume of secretion produced from nose. May experience increased blood pressure, increased anxiety, nausea, dizziness, headache, insomnia, palpitations, sleep disturbances. With long — term use tachyphylaxis, reactive hyperemia mucous membrane (sense of congestion) and atrophy of the mucous membrane of the nasal cavity.

Drug interactions:

Overdose or ingestion of Oxymetazoline and receiving tricyclic antidepressants or MAO inhibitors at the same time or immediately prior to application of Oxymetazoline can cause increased blood pressure.

Slows the absorption of local anaesthetic drugs, extends the effect.

Joint appointment other vasoconstrictor drugs increases the risk of side effects.

Method of application and dose:

The nozzle of the bottle to enter in each nostril and sharply tap once on the bottle. During injection the air to draw a nose. In the injection Noxprey not tip the head back.

Adults and children over 12 years — 1-2 injections in each nostril. Repeat injection not earlier than 12 h. Children from 6-12 years old (under adult supervision) — 1 injection every 12 hours.

Overdose:

Overdose in case of local nazalnam use sometimes leads to these system effects, such as increased heart rate (tachycardia) and increased blood pressure. In rare cases, anxiety, insomnia, fatigue, headaches and nausea.

Treatment: symptomatic.

Special instructions:

You should not use the drug more than 2 times a day. In the recommended dosage without consulting a doctor can be used not more than 5 days. Prolonged use of decongestant remedies for instillation into the nasal cavity may lead to the weakening of their actions. To avoid drug intended for intranasal administration in the eye. To avoid infection you need to use the drug individually.

Noksprey
(Oxymetazoline)
0.5mg/ml
20ml
nasal
spray

  • $5.00